Vision opens in NY, acquires Terphane

The London-based firm has opened a New York office and completed an investment in Brazilian manufacturer Terphane from Vision’s seventh fund.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this